EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systemic Inflammation in Bronchiectasis: Data from the EMBARC-BRIDGE Study

Chloe Hughes, Merete B Long, Jamie Stobo, Emma D Johnson, Kateryna Viligorska, Holly Lind, Eve McIntosh, Isavella Petrou, Qingyou Du, Chandani Hennayake, Morven Shuttleworth, Jaa Ming New und 22 weitere

American Journal of Respiratory and Critical Care Medicine · 06.11.2026

DOI: 10.1093/ajrccm/aamag590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Respiratory and Critical Care Medicine, online erschienen am 06.11.2026. Verfasst von Chloe Hughes und 33 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Medicine and Gastroenterology, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neutrophilic inflammation in the airways is associated with exacerbation risk in patients with bronchiectasis. Systemic inflammation and neutrophil function are less characterised. The aim of this study was to investigate the relationship between systemic inflammation and neutrophil function with severity of disease and clinical outcomes.

Methods

Observational international multi-centre study of adults with bronchiectasis (EMBARC-BRIDGE). Serum inflammatory profiling was performed in 487 patients using Olink® proteomics, and associations with key clinical and patient reported outcomes, including severe exacerbations during follow-up, were analysed. In a sub-study, peripheral blood neutrophils from bronchiectasis patients and controls were analysed for surface activation and functional markers, and functional responses including degranulation and neutrophil extracellular trap formation.

Results

Systemic inflammatory profiling revealed a dominant neutrophil–endothelial signature. Several proteins including PR3, AZU1, MPO, the soluble IL-33 receptor ST2, and the cellular stress marker GDF-15 were associated with increased disease severity using the bronchiectasis severity index, lower lung function, increased symptoms and for many markers, higher rates of severe exacerbations during follow-up. Neutrophils from bronchiectasis patients exhibited reduced surface CD11b and increased CXCR2, with lower CD11b correlating with lower lung function. Basal degranulation was reduced in bronchiectasis, whereas responsiveness to LPS stimulation was preserved.

Conclusion

Bronchiectasis is associated with a systemic neutrophil and endothelial inflammatory signature linked to disease severity and risk of severe exacerbations, alongside altered but functionally-responsive circulating neutrophils.

Schlagwörter

Stichwörter der Autor:innen

Bronchiectasisendothelialinflammationneutrophil

Autor:innen und Institutionen

  • Division of Respiratory Medicine and Gastroenterology, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
  • Department of Respiratory Disease, AZ Nikolaas, Belgium.
  • Pulmonology Institute and CF Center, Carmel Medical Center, Haifa, Israel.
  • Population and Health Science Institute, Newcastle University and NIHR Biomedical Research Centre for Ageing, Freeman Hospital, Newcastle, UK.
  • Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.
  • IRCCS Humanitas Research Hospital, Respiratory Unit, Via Manzoni 56, 20089, Rozzano, Milan, Italy.

Zitieren

APA

Hughes, C., Long, M. B., Stobo, J., Johnson, E. D., Viligorska, K., Lind, H., McIntosh, E., Petrou, I., Du, Q., Hennayake, C., Shuttleworth, M., New, J. M., Goeminne, P. C., Shteinberg, M., De Soyza, A., Aliberti, S., Altenburg, J., Haworth, C. S., Sibila, O., …, & Chalmers, J. D. (2026). Systemic Inflammation in Bronchiectasis: Data from the EMBARC-BRIDGE Study. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1093/ajrccm/aamag590

Vancouver

Hughes C, Long MB, Stobo J, Johnson ED, Viligorska K, Lind H, et al. Systemic Inflammation in Bronchiectasis: Data from the EMBARC-BRIDGE Study. American Journal of Respiratory and Critical Care Medicine. 2026. doi:10.1093/ajrccm/aamag590

BibTeX
@article{Hughes2026,
  author = {Hughes, Chloe and Long, Merete B and Stobo, Jamie and Johnson, Emma D and Viligorska, Kateryna and Lind, Holly and McIntosh, Eve and Petrou, Isavella and Du, Qingyou and Hennayake, Chandani and Shuttleworth, Morven and New, Jaa Ming and Goeminne, Pieter C and Shteinberg, Michal and De Soyza, Anthony and Aliberti, Stefano and Altenburg, Josje and Haworth, Charles S and Sibila, Oriol and Polverino, Eva and Loebinger, Michael and Shoemark, Amelia and Ringshausen, Felix C and Lorent, Natalie and Dimakou, Katerina and Amorim, Adelina and Mendez, Raul and McLaughlin, Anne Marie and Borrill, Zoe and Lord, Robert and Finch, Simon and Blasi, Francesco and Khan, Faisel and Chalmers, James D},
  title = {Systemic Inflammation in Bronchiectasis: Data from the EMBARC-BRIDGE Study},
  journal = {American Journal of Respiratory and Critical Care Medicine},
  year = {2026},
  doi = {10.1093/ajrccm/aamag590}
}
Kostenlos starten →